SimCorp A/S - Announcement of Managers' Transactions

Udgivet den 20-03-2020  |  kl. 09:07  |  

Announcement and public disclosure of transactions in SimCorp A/S shares by persons
discharging managerial responsibilities and persons closely associated with them

1. Details of the person with managerial responsibilities/person closely associated
a) Name Hugues Chabanis
2. Reason for the notification
a) Position/status Board member
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name SimCorp A/S
b) LEI code 5299000WVEJNSG42AK88
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Shares
DK0060495240
b) Nature of the transaction Grant of restricted stock units in connection with Corporate Bonus 2018. The restricted stock units will vest with 1/3 in each of the years 2021, 2022 and 2023.
c) Price(s) DKK 164,079
  Volume(s) 309 shares
d) Aggregated information
  Aggregated volume
  Price
N/A
e) Date of the transaction 2020-03-18  09:30 UTC
f) Place of the transaction Nasdaq Copenhagen (XCSE)


1. Details of the person with managerial responsibilities/person closely associated
a) Name Else Braathen
2. Reason for the notification
a) Position/status Board member
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name SimCorp A/S
b) LEI code 5299000WVEJNSG42AK88
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Shares
DK0060495240
b) Nature of the transaction Grant of restricted stock units in connection with Corporate Bonus 2018. The restricted stock units will vest with 1/3 in each of the years 2021, 2022 and 2023.
c) Price(s) DKK 121,599
  Volume(s) 229 shares
d) Aggregated information
  Aggregated volume
  Price
N/A
e) Date of the transaction 2020-03-18  09:30 UTC
f) Place of the transaction Nasdaq Copenhagen (XCSE)

March 20, 2020

Contact:
Questions regarding this announcement may be addressed to Martin Schak Møller, Vice President, General Counsel, SimCorp A/S, telephone +45 3544 8800.

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:43 Europa/lukning: Novo-comeback sikrede marginalt plus til europæiske aktier
17:18 Mandagens obligationer: Rolig dag på det danske obligationsmarked
17:04 Mandagens aktier: Comeback til Novo sikrede julefreden i C25
17:01 Mandagens obligationer: Renten stod i stampe på rolig dag
16:43 Zealand Pharma kroner første år i C25-indekset med titlen som den mest stigende aktie
16:06 Nordea kritiseres af tidligere chefstrateg for bureaukratiske barrierer for iværksættere
15:46 USA/åbning: Spinkel fremgang og forsigtige investorer
15:07 Arvinger køber og afnoterer amerikansk stormagasin
14:33 Vestas-analytiker: Målposten kan fortsat nås i fjerde kvartal - usikkerhed om 2025
14:10 USA/tendens: Plusserne aftager inden åbningen
13:16 Vestas modtager fire europæiske ordrer med samlet kapacitet på 151 MW
12:15 Europa/aktier: Novo Nordisk stråler i toppen af det europæiske aktiemarked
12:14 Equinor afslutter købet af 10 pct. af aktierne i Ørsted
12:01 Obligationer/middag: Julefreden indfinder sig på obligationsmarkedet
11:56 Svensk casinoudbyder styrtdykker: Undersøges af britisk spillekommission
11:50 Aktier/middag: Novo-comeback trækker C25 med op i juleslutspurt
11:14 Jeudan-topchef oplever stor kundetilgang: Er ret tilfreds med porteføljens beliggenhed
10:33 Elon Musk retter sparekniven mod "absurd overbemandet" Federal Reserve
10:26 Britisk olieserviceselskab i voldsomt kursfald efter restrukturering
10:02 Novo får amerikansk godkendelse til nyt blødermiddel